↓ Skip to main content

Cochrane Database of Systematic Reviews

Risperidone for autism spectrum disorder

Overview of attention for article published in Cochrane database of systematic reviews, January 2007
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

blogs
3 blogs
policy
2 policy sources
twitter
9 X users
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
166 Dimensions

Readers on

mendeley
283 Mendeley
citeulike
2 CiteULike
Title
Risperidone for autism spectrum disorder
Published in
Cochrane database of systematic reviews, January 2007
DOI 10.1002/14651858.cd005040.pub2
Pubmed ID
Authors

Ora S Jesner, Mehrnoosh Aref‐Adib, Esther Coren

Abstract

Autistic spectrum disorder encompasses a wide variety of behavioural and communicative problems. Both the core features and non-core features of autism have been targeted in a variety of therapies. Atypical antipsychotic medications, including risperidone, have been used for symptom and behaviour improvement and have shown beneficial outcomes, particularly in certain aspects of the disorder. However, given the nature of the condition presenting in young patients, the risks of these potentially long term therapies must be weighed against the benefits.

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 283 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 1%
India 1 <1%
Unknown 279 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 41 14%
Researcher 34 12%
Student > Bachelor 33 12%
Student > Ph. D. Student 20 7%
Other 16 6%
Other 56 20%
Unknown 83 29%
Readers by discipline Count As %
Medicine and Dentistry 89 31%
Psychology 28 10%
Nursing and Health Professions 13 5%
Social Sciences 13 5%
Neuroscience 10 4%
Other 34 12%
Unknown 96 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 36. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 March 2022.
All research outputs
#1,135,391
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#2,317
of 11,499 outputs
Outputs of similar age
#2,890
of 173,990 outputs
Outputs of similar age from Cochrane database of systematic reviews
#6
of 68 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,990 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.